These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18030515)

  • 41. [Methotrexate and non-steroidal anti-inflammatory agent combination in rheumatoid arthritis].
    Bertin P; Carpentier N; Vergne P; Bonnet C; Bannwarth B; Dehais J; Treves R
    Therapie; 1997; 52(2):133-7. PubMed ID: 9231508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasound assessment of enthesis thickening in psoriatic arthritis patients treated with adalimumab compared to methotrexate.
    Litinsky I; Balbir-Gurman A; Wollman J; Arad U; Paran D; Caspi D; Elkayam O
    Clin Rheumatol; 2016 Feb; 35(2):363-70. PubMed ID: 25073614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study.
    López Mantecón AM; Garrido G; Delgado-Hernández R; Garrido-Suárez BB
    Phytother Res; 2014 Aug; 28(8):1163-72. PubMed ID: 24344049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate.
    Gratacós J; Casado E; Real J; Torre-Alonso JC
    Ann Rheum Dis; 2007 Apr; 66(4):493-7. PubMed ID: 17179176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methotrexate in psoriatic polyarthritis.
    Pigatto PD; Gibelli E; Ranza R; Rossetti A
    Acta Derm Venereol Suppl (Stockh); 1994; 186():114-5. PubMed ID: 8073807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methotrexate achieves major cDAPSA response, and improvement in dactylitis and functional status in psoriatic arthritis.
    Appani SK; Devarasetti PK; Irlapati RVP; Rajasekhar L
    Rheumatology (Oxford); 2019 May; 58(5):869-873. PubMed ID: 30590763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
    Weinblatt ME; Keystone EC; Cohen MD; Freundlich B; Li J; Chon Y; Baumgartner SW
    J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
    Deyab G; Hokstad I; Aaseth J; Småstuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I
    J Trace Elem Med Biol; 2018 Sep; 49():91-97. PubMed ID: 29895378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients.
    Bergstra SA; Allaart CF; Stijnen T; Landewé RBM
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1473-1483. PubMed ID: 27992656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil.
    Madland TM; Björkkjaer T; Brunborg LA; Fröyland L; Berstad A; Brun JG
    J Rheumatol; 2006 Feb; 33(2):307-10. PubMed ID: 16465662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
    Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J
    Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Bongartz T; Coras B; Vogt T; Schölmerich J; Müller-Ladner U
    Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
    Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and survival of golimumab with and without methotrexate in patients with psoriatic arthritis: A retrospective study from daily clinical practice.
    Sharif K; Gendelman O; Langevitz P; Reitblat T; Watad A; Shoenfeld Y; Azuri J; Amital H; Bragazzi NL; Shovman O
    Best Pract Res Clin Rheumatol; 2018 Oct; 32(5):692-700. PubMed ID: 31203927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Deyab G; Hokstad I; Whist JE; Småstuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I
    PLoS One; 2017; 12(2):e0169830. PubMed ID: 28225768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
    Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.
    Cauza E; Hanusch-Enserer U; Frischmuth K; Fabian B; Dunky A; Kostner K
    J Clin Pharm Ther; 2006 Apr; 31(2):149-52. PubMed ID: 16635048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tenascin-C Levels, A Toll-like Receptor 4 Ligand, in Enthesitis-related Arthritis Category of Juvenile Idiopathic Arthritis: A Cross-sectional and Longitudinal Study.
    Shukla A; Gaur P; Aggarwal A
    J Rheumatol; 2015 May; 42(5):891-6. PubMed ID: 25774061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis.
    den Braanker H; Wervers K; Mus AMC; Bangoer PS; Davelaar N; Luime J; Tchetverikov I; Hazes JMW; Vis M; Lubberts E; Kok MR
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.